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Abstract
Understanding patient experience is essential to providing high quality, person-centered care. A real-time baseline crosssectional study was completed to identify gaps in patient experience that can be targeted for quality improvement (QI).
This study is part of PROSE (Person-centered Radiation Oncology Service Enhancement), a QI initiative developed to
improve patient experience at a tertiary cancer centre Radiation Oncology (RO) Department. Data was collected using
the Your Voice Matters (YVM) questionnaire. The YVM captures information on the patient’s last visit, and questions
are organized based on dimensions of person-centered care. Recruitment occurred between May and August 2019 in the
radiation department. Consecutive patients during the study period were approached to complete the YVM either in
reference to their initial consultation or previous treatment appointment. Percent positive scores were calculated for
quantitative data and a content analysis was completed for open-text data. Of 512 patients approached, a total of 400
patients participated across tumors groups. Overall, patients highly endorsed positive experiences with feeling respected
by their healthcare provider. Contacting the clinic, emotional support and wait times were rated as the least positive
components of experience across appointment types and tumors groups. The Lung tumour group demonstrated worse
experiences across all domains during treatments compared to all other tumour groups. Gaps and differences in patient
experience were demonstrated across appointment types and tumour groups. This study provides direction to effectively
develop and implement QI work aimed at improving patient experience.
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Background
Person-centered care (PCC) is a key component of health
care quality.1,2 PCC is characterized by considering the
patient as a person first and by including the patient’s
perspective and their active participation in all aspects of
their care.3 Patient experience has been defined as “the
sum of all interactions within the health care system,
shaped by an organization’s culture that influences patient
perceptions across the continuum of care.”4,5
Evaluation of patient experience includes an assessment of
specific aspects of an encounter between the patient and
health care providers, such as inclusion of the patient and
their family in decision making or coordination of their
care. Patient experience is one of the most important
measures of health care system performance and is
associated with improved communication between
patients and health care providers, adherence to
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recommended treatments, improved patient safety, lower
utilization of unnecessary health care services and better
clinical outcomes.5–8
Patient reported experience measures (PREMs) are
validated questionnaires that capture many aspects of the
patient’s experience with their health care and the quality
of care they received.9 PREMs have been primarily used to
measure and compare quality of health care systems and
performance.9 In several studies, PREMs have been used
to identify specific deficiencies in patient experience to
pursue quality improvement initiatives.10,11 PREMs are
typically administered retrospectively, and the results might
be subject to recall and/or selection bias. They often
exclude experiences of patients who are sick and unlikely
to complete the questionnaires months after their care
delivery. Further, there is little data about point-of-care
PREMs and a limited understanding of how these
measures should be used to improve the quality of care in
a cancer clinic environment. This study aims to address
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these gaps by administering a near real-time PREM tool to
patients in clinic to identify gaps in patient experience that
could lead to quality improvement (QI) work.

Methods
Study Design

This was a comprehensive real-time cross-sectional study
using a point-of-care validated PREM tool (Your Voice
Matters). Data were collected across tumour groups and at
two different appointment types (initial consultations and
radiation treatment appointments). This study was a
baseline PROSE project.

PROSE program

The PROSE program (Person-centered Radiation
Oncology Service Enhancement) is a multiyear
programmatic QI initiative established to improve patient
experience and quality of care in the radiation oncology
department at a tertiary cancer centre. The PROSE team
includes health services researchers, a radiation oncology
fellow and a clinical program coordinator. A quality
council provides additional oversight and opportunity for
stakeholder involvement. Its membership includes content
experts, leadership from the oncology department and
patient advisors. The program aims to identify and target
gaps in patient experience within the radiation department
and engage the entire radiation therapy (RT) department
team to participate in QI projects led by PROSE. The
ultimate program goal is a departmental culture shift
towards person-centered care.
The PROSE program’s ethics proposal was reviewed and
approved by the Health Research Ethics Board of Alberta
(HREBA) – Cancer Committee (CC) on October 2, 2018
(protocol identifying number: HREBA.CC-18-0588).

Your Voice Matters (YVM) Survey

Patient experience data were collected using Your Voice
Matters (YVM). This electronic survey was developed and
validated by CancerCare Ontario (CCO) for real-time use
in an outpatient oncology setting.12 The 28-core item
YVM was a product of a psychometric validation study.12
The tool underwent cognitive testing with patient advisors,
was administered using various delivery modes (paper,
tablets, patient portals, etc.) and was piloted at 6 cancer
centres. Reliability and validity of the tool was calculated
using Cronbach’s alpha and multivariable regression
analyses.12
The YVM domains and sub-questions reflect the order of
the patient journey, including arrival to the clinic, wait
times, the appointment, departure and overall experience.
This project used the original 28-item version.
The structured YVM questions collect quantitative data.
Most questions use a 5-point scale and ask patients to rate
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their experiences with response options including
excellent, very good, good, fair, poor. The survey also
included Yes/No questions. Two open-text questions
allowed patients to provide feedback on improving their
patient experience.
The YVM was administered for patients to complete
electronically on tablet devices. Data were collected and
managed using a secure, web-based software platform
REDCap hosted at the University of Calgary.13,14

Sampling

Adult cancer patients attending an initial consultation with
a radiation oncologist or radiation treatment appointment
were eligible to participate. A convenience sample
stratified by tumour group was used to obtain a
representative sample across cancer sites. The aim was to
obtain a total sample of 400 patients, 200 referencing their
consultation and 200 referencing their treatment.

Recruitment

Recruitment occurred from May to August 2019 and was
completed by the research coordinator. Survey completion
was voluntary and anonymous. Patients were recruited
from the CT simulation/radiation treatment waiting areas.
Patients recruited from CT simulation whose previous
appointment was a consultation were asked to complete
the YVM in reference to their consultation. Patients whose
previous visit was a radiation treatment were asked to
complete the YVM in reference to that appointment.
Waiting areas and times of day are common to all patients
attending the appointments and they are not specific to
tumour groups. The research coordinator recruited from
various waiting areas per day and at various time points
within clinic hours.

Analysis
Percent Positive Scores

We analyzed this project’s YVM data using percent
positive scores and following the CCO analysis plan for
consistency. Percent positive scores (the proportion of
positive experience responses) were calculated for
quantitative YVM items using the equation: Percent
Positive Score (%) = Positive / (Positive + Negative) X
100.
For questions using a scale of excellent to poor, positive
responses included ‘excellent’ and ‘very good’. The
denominator included all responses, excluding ‘not
applicable’ and ‘don’t know’. For yes/no questions, the
positive response was context-dependent, with the
denominator being the sum of yes and no responses.
Percent positive scores were overlaid with a heat map to
visualize differences in scores across appointment types
and tumour groups. Darker colours represent more
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positive experiences and lighter colours represent less
positive experience.

responsiveness (50.9%; 45.4%), and discussing worries &
concerns (53.6%; 62.4%).

For each table, YVM items were grouped by dimensions
of person-centered care including: Access to Care;
Information & Education; Patient Preference; Physical
Comfort; Emotional Support; Family & Friends;
Coordination of Care, and; Continuity & Transitions
15,16[Table 1, 2]. We also included an Overall Experience
section in our results.

Experience by Dimensions of Person-Centered Care

Logistic Regression

Access to Care. Overall, the options available to patients
to contact the clinic received the lowest percent positive
scores at consultation (32.7%) and treatment (25.0%)
appointments (Table 1, 2). Most patients during
consultations (84.0%) and treatments (85.0%) had positive
experiences with the length of time healthcare providers
spent with them, with positive experience scores >80%
across all tumour groups, except lung (63.0%).

Content Analysis

Information, Communication & Education. Most patients
during treatment appointments felt listened to (93.5%),
things were explained well (86.5%) and they could ask
questions (95.0%), with positive experience scores
consistently higher compared to consultations by 8.0%,
4.5% and 2.5%, respectively.

Multivariable logistic regression was conducted for overall
experience. The overall experience YVM responses were
dichotomized into positive/negative patient experience
outcome. Covariates included demographic variables
(gender, age, education), appointment type (consultation,
radiation treatment) and tumour group. Statistical tests
were performed with a significance level of 5%.
Two open-text questions included: “Is there one thing that
would have made your last visit to the Cancer Centre
better?” and “Was there something at your visit that you
wanted to give feedback on that is not asked in this
survey?” Responses were analyzed using a content analysis.
All comments were organized based on appointment type
and codes were organized into themes. Two separate
reviewers (DY and PG) coded each comment
independently and differences were resolved by discussion.

Results
A total of 513 patients were approached to participate in
the study. Between May and August 2019, 400 patients
(78%) agreed to complete the YVM. Two-hundred
patients completed the YVM in reference to their
consultation and 200 in reference to their last radiation
treatment appointment. Demographics and sample sizes
by tumour groups are shown in the Appendix, Table 3.
Tumour groups included: Brain, Breast, Gastrointestinal
(GI), Gynecology (Gyne), Head and Neck (H&N), Lung,
Prostate/Testicular and Other.

Percent Positive Scores
Overall Experience

Overall experience percent positive scores for
consultations and treatment appointments were 79.9% and
85.0%, respectively. The highest positive experience scores
>90% included confidence in the system, reception being
polite, being treated with respect, feeling involved in
decisions and inclusion of friends & family. The lowest
experience scores were reported for options/methods of
contacting the clinic (32.7% for consultations and 25.0%
for treatments), wait times (38.0%; 22.0%), clinic
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Participants reported highest experience scores during
both radiation consultations and treatments within the
dimensions of “Patient Preferences”, “Family & Friends”
and “Information, Communication & Education”. The
dimensions “Emotional Support” and “Coordination of
care” received the lowest scores (Table 1, 2).

How the clinic responded to patients who had contacted
the clinic reflected low experience scores for both
consultations (50.9%) and treatments (45.4%). Scores
varied across tumour groups and were lowest for the brain
tumour group during consultations (64.0%). The largest
difference in positive experience scores between
appointments was the information patients received about
their care plan, in which 12.4% more patients during
treatment reported a positive experience compared to
consultations.
Patient Preferences and Friends & Family. Patient
preferences percent positive scores were positive during
both encounters. Positive experience scores were >90%
for the reception staff being polite and patients feeling
respected.
More patients felt included in decisions about their care
during treatment (86.7%) compared to consultations
(79.6%). During consultations, Other (68.0%), Lung
(68.2%) and H&N (69.2%) groups reported the lowest
experience scores. During treatment, Lung reported the
lowest experience score (74.1%) for feeling involved in
decisions. Most patients during consultations (92.5%) and
treatment (95.0%) had a positive experience with involving
friends and family in their care.
Physical Comfort. Overall positive experience scores for
discussing physical symptoms with healthcare provider(s)
were 81.0% and 87.9% for consultation and treatment
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appointments, respectively. The largest difference in scores
between appointments was patients’ comfort in the
waiting areas, as 18.5% less patients reported treatment
waiting areas as comfortable/clean compared to
consultations. The Gyne tumour group reported the
lowest experience scores for the waiting area being
comfortable/clean for both consultations (55.0%) and
treatment (50.0%) appointments.
Emotional Support. Discussing emotional worries and
concerns received low patient experience scores during
consultations (53.6%) and treatment (62.9%). During
consultations, scores ranged from Gyne (27.8%) to Breast
(78.3%). The Lung tumour group indicated the lowest
treatment score (42.1%).
Coordination of Care and Continuity & Transitions.
During consultations, only 38% of patients did not have to
wait past their appointment time and 55.3% reported a
positive experience with their wait time. Breast patients
stood out with the highest positive experience score
(73.1%) regarding waiting for the consultation to start.
Compared to consultations, 16% more patients had to wait
past their treatment appointment time and 15% less
patients had a positive experience with their treatment wait
times. Positive experience scores for waiting for treatment
appointments ranged from 30.0% in Gyne to 57.1% in
Breast patients. Most patients reported positive
experiences with the coordination of their radiation
oncology care team during consultations (76.9%) and
treatment (82.9%) appointments.
More patients during treatments reported positive
experiences with receiving clinic contact information
(84.9%), knowing next steps in their care plan (96.5%) and
receiving clear guidelines/instructions (84.6%), with scores
higher than consultations by 9.4%, 22.0% and 11.1%,
respectively.

Logistic regression

Multivariable logistic regression results demonstrated
patients with breast (OR=3.82, p=0.041), GI (OR=7.93,
p=0.012) and prostate cancer (OR=3.86, p=0.030) were
more likely to have a positive overall experience compared
to lung (reference group). Patients over the age of 60
(OR=2.90, p=0.039) were more likely to report a positive
overall experience compared to the age group 18-40.
Gender, education and appointment type were not
statistically significant. We did not have enough power in
our sample to stratify our analysis by appointment type.

Content Analysis
Consultation Appointments

A total of 104 open-text comments were documented for
initial consultations (Table 4). The most frequently
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reported concerns were in the “Access to Care” dimension
(n=38), including concerns with contacting the clinic,
burdensome parking and transportation. One patient
stated “Not a good experience trying to contact [the cancer centre].
Completely roundabout and frustrating experience. Only thing that
has been an issue...” The “Information, Communication &
Education” dimension received 33 comments and
included a lack of clinical information and scheduling
issues. The third highest number of comments were in the
“Coordination of Care” dimension (n=22), with patients
reporting long wait times: “Had to wait over two and a half
hours…very long and not a good feeling to wait so long when newly
diagnosed and not so sure what is going on.” Few comments
were reported regarding the remaining dimensions.

Treatment Appointments

There were 125 open-text comments regarding treatment
encounters (Table 4). The most frequently documented
comments pertained to “Access to Care” (n=56), including
parking concerns and transportation. The second highest
number of comments were in “Coordination of Care”
(n=37), mainly issues with wait times and a lack of
coordination within the radiation department. As one
patient noted: “Treatment runs late, then late for review or miss
other appointments like OT. Better coordination, so no appointments
are missed.” The third most common dimension was
“Physical Comfort” (n=21), including physical and
environmental discomforts, such as uncomfortable seating
or lack of wi-fi. Relatively high number of comments
related to issues within “Information, Communication &
Education” (n=19), however less frequent compared to
Consultations. Few comments were documented regarding
issues with “Patient Preferences” or “Continuity &
Integration.”

Discussion
This study reports on the experiences of patients coming
for radiation oncology consultations and radiation therapy
appointments at a tertiary cancer centre, using a validated
point-of-care questionnaire related to a specific encounter.
Consistently high patient experience scores across
appointment types and tumour groups included the
domains of “Patient preferences” and “Family & Friends,”
specifically with patients feeling respected, including family
and friends in their care, and with polite reception staff.
Compared to consultations, treatment experiences were
more positive for “Information, Communication &
Education” and “Continuity & Transitions” dimensions.
Scores within “Coordination of Care” in reference to wait
times were consistently low, and worse during treatment.
“Physical Comfort” dimension, specifically the comfort of
the waiting areas, were lower during treatment compared
to consultations.
Long wait times, delays in treatment start, lack of
coordination and emotional support as limitations to
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optimal cancer patient experience have been consistently
reported in other studies.17–24 A Canadian study by Hashmi
et al. used a minute survey to obtain patient experience
data from patients undergoing radiation therapy.25 In this
study, 83% of participants reported excellent experience in
radiation oncology. The most common feedback for
improving experience included same day waits and better
management of appointment delays. Bridge et al. noted in
their qualitative analysis of Ontario AOPSS data that
patients had experienced delays at all steps of their
encounters, including waiting for tests, for their providers,
as well as treatments.23 Patients reported concerns with
long wait times in our study, shown through low
“Coordination of Care” scores and a high frequency of
open-text comments. Coordination of care within the
cancer centre and with other providers has become more
complex, with increased need for multi-disciplinary and
interdisciplinary care. Finding a balance between
interdisciplinary single day appointments and the
exhaustion of long appointments is required.
Hashmi et al. found environmental improvements to be
the second most common recommendation, including
more distractions in waiting areas and functional wifi,
similar to our findings.25 Parking and appointment
scheduling were less common gaps in their study,23
compared to our results. Bridge et al. also noted stress
regarding accessibility and cost of parking frequently
reported on patients’ comments.2 Amenities including
parking have been considered separate from patient
experience and quality of care and are not included in
structured PREMs questions but are frequently reported
on free-text comments and may impact overall experience
scores.11,17,23 Other consistently low items across
appointment and tumour groups included options of
contacting the clinic and discussing emotional worries.
Low scores for discussing emotional worries have been
consistently reported in the literature,26,27 despite presence
of clinical guidelines for anxiety and depression in
oncology patients. Continued research and QI work is
needed to help improve emotional wellbeing for
patients.28,29
Sociodemographic factors have been shown to be
associated with patient experience in previous studies.30,31
Of cancer patients completing the YVM survey in Ontario,
males and genitourinary cancer patients were more likely
to have a positive patient experience.30 Patients aged 18-39
were more likely to have a negative experience compared
to 65+ patients30,31 as were patients in the lowest income
bracket.30 Patients diagnosed with central nervous system
(CNS) or lung cancer were more likely to report a negative
experience.30,31 Similarly, we found older patients and
those diagnosed with prostate cancer were more likely to
report positive overall patient experience, as did GI
patients in our study.
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This study identified important differences in patient
experience among tumor groups. The gynecological
patients had particularly poorer experiences with wait
times and physical comfort. However, over 95% of
gynecological patients responded positively to the overall
quality of care they received, indicating the physical clinic
environment is affecting their overall experience, possibly
related to their distinct physical symptoms. QI initiatives
to address this discomfort may include adding more
comfortable seating options in the waiting area, such as
recliner chairs or donut seating.
Breast and prostate patients had the highest percent
positive scores for YVM categories. This may reflect the
high incidence of these cancers resulting in wellestablished supports and resources. Additionally, higher
proportions of these patients receive curative intent
treatments and are overall well. While YVM did not
include questions about intent of treatment, Watson et al.
showed lower experience scores in ambulatory cancer
patients with palliative-intent treatments, compared to
patients treated with curative intent.32 Although lung
cancer is among the most common cancers, patient
experience during treatment is consistently poorer relative
to the other tumour groups. Other studies have also
reported on less favourable experience scores of patients
with lung cancer compared to other tumour groups, such
as breast and colorectal cancer.33,34 Reasons for poor
patient experience have been attributed to diagnostic
delays,35 poor symptom management/support26,27 and
poor communication with healthcare professionals.26
Similarly, our results may highlight the relative lack of
resources available to lung cancer patients. Additionally,
due to the severity and nature of lung cancer, radiation
treatment is more commonly given with palliative intent.
Specific supports or strategies, such as early specialized
palliative care referral, may be needed to personalize the
care appropriate to these patients’ specific clinical needs.
The results of this study helped prioritize and develop
future QI work in the department based on tumourspecific results. Oncology practice at our department and
across our province is primarily operated within
multidisciplinary tumor group teams. Our results have
facilitated discussions with the lung tumor group clinicians
on enhancing aspects of care to better address patient
needs. PROSE has also conducted further follow up
studies to investigate why patients with lung cancer in our
radiation department report worse treatment experience. A
retrospective chart audit found patients with lung cancer
have greater diagnostic delays between initial investigations
and receiving a diagnosis, as well as more severe symptoms
on treatment compared to patients with GI cancer at our
institution.36 One of the limitations to the results of this
study is an inability to link our patient experience data with
other outcome data, such as the diagnostic delays or
symptom severity. Anonymous data collection in this
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patient experience study was done to promote safe
reporting by participants. Future patient experience studies
can be designed to either collect more clinical data from
patients by including additional questions or add patient
identifiers to link participants to other clinical data.
Additional data that would be useful to collect include the
patients’ current treatment details (i.e. are they receiving
radiation alone vs. concurrent chemoradiation; intent of
treatment), as these factors likely have impacted patient
experience.

actual process of investigating patient experience and
defining quality improvement strategies remains the same.
Further, collection of PREMs should encourage
responsive actions to improve evident gaps in patient care.
Therefore, our study can be used as a framework for other
organizations/QI teams. Understanding and improving
patient experience can in return improve the quality of
care that patients receive at their institution.

Other patient experience gaps identified by this study are
being addressed by ongoing projects. The Division of
Radiation Oncology at our institution has piloted a care
pathway, where patients receive their CT simulation
appointment date and time prior to leaving their
consultation, aiding patients in knowing their next steps.
Other deficiencies addressed across our health authority
include the Mycare Conversation App – developed to
securely record conversations during consultations.

This study shows variation in patient experience across
different appointment types and tumour groups. Patient
experience was consistently positive for meeting patient
preferences and including family and friends in patient
care plans. Areas for improvement include managing wait
times and improving physical comfort. Across both
appointments, improving the process for contacting the
clinic as well as improving emotional support can be areas
for quality improvement work within the radiation
department. These observations will help guide future
evaluations and interventions.

There were several limitations to this study, including the
small number of patients in each tumour group. Small
sample sizes limited stratification and more in-depth
statistical analyses. Another limitation may include
response bias, as unwell patients may have been less likely
to complete the survey, however we obtained a relatively
high response rate (78%) which can help reduce
nonresponse bias. Although the YVM was developed for
patients to complete the tool in reference to their last
clinic visit, it is possible that some patients completed the
tool in reference to more general cancer centre
experiences. Therefore, results may reflect general
experiences in addition to the intended specific single-visit
experience. Further, anonymous data collection did come
with limitations regarding interpretation of our data and
linkage to other important outcomes. A strength of this
study was having greatly minimized recall bias by asking
patients to complete the YVM in near real-time. Another
strength includes using the YVM in a specific department.
CCO utilizes the YVM by collecting patient experience
data on a province-wide scale. Although the large-scale
implementation in Ontario produces important data for
institutional comparisons, we have demonstrated the value
in implementing the YVM in a small-scale singleinstitution and department setting. Our results can
effectively direct and prioritize QI work within our
radiation department context, whereas high-level aggregate
data can disguise otherwise important trends and findings.
This study can be of value to other organizations looking
to undergo quality improvement work. Our study
demonstrates the use of a PREM to highlight strengths
and weaknesses of care within a department, and direct
where resources would be most effective to improve
patient experience. Specific results from a PREM will
likely differ across institutions and departments but the
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Appendix
Table 1. Percent Positive Scores (%) for Consultation Experiences by Tumour Groups
Dimensions of
Person-centered
Care

YVM Question
Options available to contact clinic
Convenient hours
Access to Care
Clinic is easy to find
Spent enough time
How the clinic responded
Listened to you
Information,
Communication & Explained things well
Education
Let you ask questions
Information provided
Reception was polite
Patient Preferences Treat you with respect
Involved in decisions
Wait room comfortable and clean
Physical Comfort
Discussed symptoms
Exam room comfortable and clean
Emotional Support Discussed worries and concerns
Family & Friends
Involved friends or family
Wait time past appointment*
Wait time to check-in
Coordination of
Care
Wait time for appointment
Coordination of team
Contact information provided
Continuity &
Next steps provided**
Transitions
Clear guidelines/instructions given
Arrival experience (reception, waiting area, wait
times)
Overall
Experiences
Quality of care received during appointment
Overall last visit experience
Overall confidence in the health system
*YVM item with yes/no response. “No” is the positive response.
**YVM item with yes/no response. “Yes” is the positive response.
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Brain
(n=25)
62.5
71.4
60.0
76.0
75.0
88.0
64.0
96.0
60.0
88.0
100.0
84.0
64.0
84.0
64.0
56.5
96.0
36.0
80.0
48.0
80.0
76.0
68.0
68.0

Breast
(n=26)
40.0
87.5
73.1
96.2
70.0
92.3
96.2
100.0
92.3
100.0
100.0
88.5
100.0
88.5
92.3
78.3
100.0
76.9
88.5
73.1
92.3
96.2
80.8
88.5

GI
(n=26)
50.0
82.6
69.2
92.3
100.0
84.6
84.6
88.5
84.6
92.3
92.3
88.5
92.3
88.5
88.5
60.0
91.7
42.3
88.5
65.4
84.6
80.8
80.0
80.8

Gyne
(n=20)
20.0
90.1
55.0
70.0
40.0
85.0
75.0
95.0
65.0
100.0
100.0
80.0
55.0
72.2
65.0
27.8
100.0
10.0
73.7
31.6
75.0
70.0
75.0
70.0

H&N
(n=26)
0.0
72.7
76.0
76.9
40.0
88.5
76.9
84.6
69.2
96.2
88.5
69.2
76.9
76.9
76.9
41.7
82.6
26.9
80.8
50.0
73.1
76.9
69.2
73.1

Lung
(n=25)
33.3
68.4
76.0
84.0
33.3
72.0
84.0
88.0
64.0
96.0
88.0
68.2
88.0
69.6
84.0
54.5
86.4
52.0
76.0
56.0
72.0
68.0
84.0
68.0

Prostate
(n=26)
20.0
87.5
80.8
100.0
20.0
88.5
92.3
100.0
69.2
96.2
100.0
88.5
92.3
84.0
92.3
58.3
100.0
30.8
76.9
53.8
84.6
69.2
60.0
84.6

Other
(n=26)
33.3
77.3
57.7
73.1
55.6
84.6
80.8
88.5
57.7
96.2
96.2
68.0
69.2
80.8
76.9
42.3
83.3
23.1
72.0
57.7
65.4
65.4
76.0
53.8

Total
Consultation
(n=200)
32.7
79.5
68.8
84.0
50.9
85.5
82.0
92.5
70.5
95.5
95.5
79.6
80.5
81.0
80.5
53.6
92.5
38.0
79.8
55.3
78.5
75.5
74.2
73.5

68.0

100.0

76.9

50.0

73.1

72.0

73.1

64.0

72.8

80.0
72.0
92.0

92.3
96.2
100.0

84.6
88.5
88.5

95.0
57.9
100.0

80.8
80.8
80.8

76.0
76.0
76.0

100.0
92.3
96.2

69.2
69.2
80.8

84.5
79.9
91.5
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Appendix
Table 2. Percent Positive Scores (%) for Treatment Experiences by Tumour Groups
Dimensions of
Person-centered
Care

YVM Question
Options available to contact clinic
Convenient hours
Access to Care
Clinic is easy to find
Spent enough time
How the clinic responded
Listened to you
Information,
Communication &
Explained things well
Education
Let you ask questions
Information provided
Reception was polite
Patient Preferences
Treat you with respect
Involved in decisions
Wait room comfortable and clean
Physical Comfort
Discussed symptoms
Exam room comfortable and clean
Emotional Support
Discussed worries and concerns
Family & Friends
Involved friends or family
Wait time past appointment*
Wait time to check-in
Coordination of care
Wait time for appointment
Coordination of team
Contact information provided
Continuity &
Next steps provided**
Transitions
Clear guidelines/instructions given
Arrival experience (reception, waiting area, wait
times)
Quality of care received during appointment
Overall Experiences
Overall last visit experience
Overall confidence in the health system
*YVM item with yes/no response. “No” is the positive response.
**YVM item with yes/no response. “Yes” is the positive response.
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Brain
(n=25)
44.4
83.3
64.0
88.0
55.6
96.0
84.0
100.0
87.5
92.0
96.0
84.0
64.0
84.0
88.0
61.9
95.7
20.0
75.0
36.0
92.0
92.0
100.0
72.0

Breast
(n=28)
0.0
100.0
64.3
89.3
40.0
96.4
89.3
92.9
85.7
92.9
96.4
92.9
64.3
88.5
89.3
68.0
96.0
10.7
92.9
57.1
85.7
85.7
92.9
85.7

GI
(n=26)
25.0
91.7
61.5
96.2
50.0
96.2
96.2
100.0
92.3
100.0
96.2
91.7
53.8
91.7
92.3
66.7
95.8
34.6
88.5
42.3
92.3
88.5
100.0
96.2

Gyne
(n=20)
28.6
78.9
45.0
90.0
42.9
100.0
90.0
100.0
85.0
100.0
100.0
95.0
50.0
95.0
75.0
58.9
100.0
25.0
85.0
30.0
90.0
80.0
100.0
85.0

H&N
(n=26)
40.0
88.0
76.9
80.8
60.0
100.0
92.3
92.3
84.6
100.0
96.2
85.4
69.2
88.5
76.9
71.4
95.8
26.9
73.1
42.3
84.6
92.3
96.2
84.0

Lung
(n=27)
0.0
74.1
65.4
63.0
25.0
77.8
66.7
85.2
66.7
85.2
81.5
74.1
51.9
80.8
70.4
42.1
85.2
22.2
73.1
30.8
63.0
70.4
92.6
74.1

Prostate
(n=26)
40.0
100.0
80.8
92.3
80.0
96.2
88.5
96.2
96.2
100.0
92.3
92.0
80.8
91.3
92.0
75.0
96.0
19.2
92.3
46.2
96.0
96.0
96.2
88.5

Other
(n=22)
0.0
95.5
54.5
81.8
0.0
86.4
86.4
95.5
68.2
90.5
90.9
81.0
59.1
85.0
90.9
64.3
95.2
18.2
100.0
36.4
59.1
72.7
95.2
77.3

Total
Treatment
(n=200)
25.0
89.7
64.8
85.0
45.4
93.5
86.5
95.0
82.9
94.9
93.5
86.7
62.0
87.9
84.4
62.4
94.7
22.0
84.8
40.7
82.9
84.9
96.5
84.6

72.0

71.4

65.4

55.0

65.4

59.3

80.8

50.0

65.5

96.0
80.0
100.0

92.9
85.7
96.4

100.0
96.2
96.2

100.0
95.0
100.0

92.3
76.9
96.2

85.2
70.4
92.6

92.3
88.5
96.2

95.5
90.0
90.9

94.0
85.0
96.0
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Table 3. Demographic Data of the Study Population
Demographic
Gender (n, %)
Male
Female
Total (n)
Age (n, %)
18 to 40
41 to 60
Over 60
Total (n)
Highest grade of school completed (n, %)
Some high school/grade 9 or less
High school graduate
College, trade or technical school
University undergraduate degree
Post-university/graduate education
Total (n)
Cancer Type (n, (%)
Brain
Breast
Gastrointestinal (GI)
Gynecology (Gyne)
Head and Neck (H&N)
Lung
Prostate
Other
Total (n)

Patient Experience Journal, Volume 9, Issue 1 – 2022

Consultation

Treatment

Total

104 (52.0%)
96 (48.0%)
200

97 (51.5%)
103 (48.5%)
200

201 (50.2%)
199 (49.8%)
400

13 (6.5%)
58 (29.0%)
129 (64.5%)
200

21 (10.7%)
67 (34.2%)
108 (55.1%)
196

34 (8.6%)
125 (31.6%)
237 (59.8%)
396

19 (10.2%)
44 (23.5%)
64 (34.2%)
44 (23.5%)
16 (8.6%)
187

20 (10.9%)
42 (23.1%)
54 (29.7%)
49 (26.9%)
17 (9.3%)
182

39 (9.9%)
86 (23.3%)
118 (31.9%)
93 (25.2%)
33 (8.9%)
369

25 (12.5%)
26 (13.0%)
26 (13.0%)
20 (10.0%)
26 (13.0%)
25 (12.5%)
26 (13.0%)
26 (13.0%)
200

25 (12.5%)
28 (14.0%)
26 (13.0%)
20 (10.0%)
26 (13.0%)
27 (13.5%)
26 (13.0%)
22 (11.0%)
200

50 (12.5%)
54 (13.5%)
52 (13.0%)
40 (10.0%)
52 (13.0%)
52 (13.0%)
52 (13.0%)
48 (12.0%)
400
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Appendix
Table 4. Content Analysis of Patient Feedback for Improving Patient Experience
Dimension of Personcentered Care

Consultation*
Frequency (n)
of comments
8

Treatment**
Frequency (n)
of comments
13

Parking: Cost

4

16

Transportation burdensome

10

10

Clinic location challenging to find

6

8

Lack/delay in accessing supportive services

3

2

Inability to contact TBCC
Inconvenient scheduling (form of appt. booking, suggested use of email)
Total count for Access to Care

3
4
38

3
0
52

Lack of scheduling information/confusion with scheduling

13

4

Lack of clinical information

9

4

Issues with form of information (for patients with difficulty comprehending/ retaining
information, e.g. central nervous system involvement)

4

4

Negative interaction with healthcare provider (poor communication skills)

2

4

Delay in healthcare provider calling the patient back

2

1

Lack of confidence about quality of care
Information not right for the person (focus on clinical trials and not on personal clinical
information)

1

1

1

0

Clarity about the roles of healthcare professional and who to contact

1

0

Lack of information/guidance on support groups

0

1

Total count for Information, Communication & Education

33

19

Did not feel included in decisions about care

2

1

Preference for consistent RT staff

-

3

Scheduled appointment times not patient's preference

0

2

Total count for Patient Preferences

2

6

Wi-fi not functional

3

6

Uncomfortable physically (e.g. symptoms/side-effects of pain/discomfort)

0

8

Uncomfortable physical space (waiting area is uncomfortable)

2

7

Immobilization mask very claustrophobic

2

0

Total count for Physical Comfort

7

21

Uncertainty/overwhelmed

2

1

Lack of attention/empathy to patient's concerns (e.g. anxiety with immobilization mask)

2

0

Anxiety caused by changes/delays in treatment plans (lack of explanation)

0

3

Total count for Emotional Support

4

4

Wait times

10

19

Lack of coordination within the clinic
Lack of coordination within TBCC (RT and chemo)

2

8

2

5

Lack of coordination between TBCC and other clinics/places (e.g. ER)

4

2

Missed check-in

4

1

Total count for Coordination of Care

22

35

Uncertain where to call with more questions/wish to address further/follow-up

3

1

Missing information about next steps

1

1

Total count for Continuity & Integration of Care

4

2

Positive interaction with healthcare professional

4

4

General Comment

4

2

Total count for Positive Experience

8

6

Themes
Parking: Accessibility

Access to Care

Information,
Communication &
Education

Patient Preferences

Physical Comfort

Emotional Support

Coordination of Care

Continuity &
Integration of Care

Other: Positive
Experience

* There were 104 total comments documented for consultations. Comments could be coded into more than one theme.
** There were 125 total comments documented for treatments. Comments could be coded into more than one theme.

130

Patient Experience Journal, Volume 9, Issue 1 – 2022

